Palpitation secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
No edit summary Tags: mobile edit mobile web edit |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Palpitation}} | {{Palpitation}} | ||
{{CMG}} {{AE}}{{ | {{CMG}} {{AE}}{{Akash}} | ||
==Overview== | |||
There are no established measures for the [[secondary prevention]] of [[palpitations]]. | |||
==Secondary Prevention== | |||
[[Secondary prevention]] | |||
*There are no established measures for the [[secondary prevention]] of [[palpitations]]. | |||
*Effective measures for the [[secondary prevention]] of [[palpitations]] include: <ref name="pmid21697315">{{cite journal| author=Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L | display-authors=etal| title=Management of patients with palpitations: a position paper from the European Heart Rhythm Association. | journal=Europace | year= 2011 | volume= 13 | issue= 7 | pages= 920-34 | pmid=21697315 | doi=10.1093/europace/eur130 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21697315 }} </ref> | |||
**[[Medication compliance]] | |||
**Avoidance of [[triggers]] such as [[caffeine intake]], [[alcohol abuse]]. | |||
**Cessation of [[substance abuse]] ([[cocaine]], [[amphetamines]], [[alcohol]], [[MDMA]]) | |||
**However, individuals who are involved in certain occupations (eg pilots, commercial truck drivers) and have a history of [[palpitations]] would require [[specialist referral]] and should discontinue such activities until clearance is obtained. <ref name="pmid31256490">{{cite journal| author=McLellan AJ, Kalman JM| title=Approach to palpitations. | journal=Aust J Gen Pract | year= 2019 | volume= 48 | issue= 4 | pages= 204-209 | pmid=31256490 | doi=10.31128/AJGP-12-17-4436 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31256490 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
| Line 10: | Line 25: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Latest revision as of 14:23, 16 August 2020
|
Palpitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Palpitation secondary prevention On the Web |
|
American Roentgen Ray Society Images of Palpitation secondary prevention |
|
Risk calculators and risk factors for Palpitation secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
There are no established measures for the secondary prevention of palpitations.
Secondary Prevention
- There are no established measures for the secondary prevention of palpitations.
- Effective measures for the secondary prevention of palpitations include: [1]
- Medication compliance
- Avoidance of triggers such as caffeine intake, alcohol abuse.
- Cessation of substance abuse (cocaine, amphetamines, alcohol, MDMA)
- However, individuals who are involved in certain occupations (eg pilots, commercial truck drivers) and have a history of palpitations would require specialist referral and should discontinue such activities until clearance is obtained. [2]
References
- ↑ Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L; et al. (2011). "Management of patients with palpitations: a position paper from the European Heart Rhythm Association". Europace. 13 (7): 920–34. doi:10.1093/europace/eur130. PMID 21697315.
- ↑ McLellan AJ, Kalman JM (2019). "Approach to palpitations". Aust J Gen Pract. 48 (4): 204–209. doi:10.31128/AJGP-12-17-4436. PMID 31256490.